Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers

American Journal of Clinical Nutrition

Volumn 89, Issue 5, 2009, Pages 1321-1327

  Zittermann, Armin ^a   Frisch, Sabine ^a   Berthold, Heiner K ^b   Götting, Christian ^a   Kuhn, Joachim ^a   Kleesiek, Knut ^a   Stehle, Peter ^c   Koertke, Heinrich ^a   Koerfer, Reiner ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYERGOCALCIFEROL; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALCIFEDIOL; CALCITRIOL; CALCIUM; COLECALCIFEROL; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PARATHYROID HORMONE; PLACEBO; PROINSULIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D;

ADULT; AGED; ARTICLE; BODY FAT; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PARATHYROID HORMONE BLOOD LEVEL; PATIENT COMPLIANCE; SEX DIFFERENCE; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; WEIGHT REDUCTION; ADIPOSE TISSUE; BLOOD; CONTROLLED CLINICAL TRIAL; DIET SUPPLEMENTATION; DRUG EFFECT; HISTOLOGY; INFLAMMATION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ADIPOSE TISSUE; ADULT; BIOLOGICAL MARKERS; CALCIFEDIOL; CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PLACEBOS; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN D; WEIGHT LOSS;

EID: 65549137566     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.3945/ajcn.2008.27004     Document Type: Article

References (53)

1. Caballero B. The global epidemic of obesity: an overview. Epidemiol Rev 2007;29:1-5.
2. World Health Organisation (WHO). Obesity and overweight. September 2006, Fact sheet no. 311. Available from: http://www.who.int/mediacentre/factsheets/ fs311/ en/index.html(cited 10 September 2008.
3. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006;295:1549-1555
4. Bray GA, Bellanger T. Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Endocrine 2006;29:109-117 (Pubitemid 43780352)
5. Sarti C, Gallagher J. The metabolic syndrome: prevalence, CHD risk, and treatment. J Diabetes Complications 2006;20:121-132 (Pubitemid 43295378)
6. Moller DE, Kaufman KD. Metabolic syndrome: a clinical and molecular perspective. Annu Rev Med 2005;56:45-62. (Pubitemid 40299773)
7. Snijder MB, van Dam RM, Visser M, et al. Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J Clin Endocrinol Metab 2005;90:4119-4123 (Pubitemid 41058184)
8. Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 2008;168:1174-1180 (Pubitemid 351831400)
9. Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med 2008;168:1340-1349 (Pubitemid 351930842)
10. Zittermann A. Vitamin D and disease prevention with special reference to cardiovascular disease. Prog Biophys Mol Biol 2006;92:39-48. (Pubitemid 43831966)
11. Kamycheva E, Sundsfjord J, Jorde R. Serum parathyroid hormone levels predict coronary heart disease: the Tromsø Study. Eur J Cardiovasc Prev Rehabil 2004;11:69-74. (Pubitemid 38388927)
12. Parikh SJ, Edelman M, Uwaifo GI, et al. The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab 2004;89:1196-1199 (Pubitemid 38368412)
13. Konradsen S, Ag H, Lindberg F, Hexeberg S, Jorde R. Serum 1,25-dihydroxy vitamin D is inversely associated with body mass index. Eur J Nutr 2008;47:87-91.
14. Zittermann A, Koerfer R. Protective and toxic effects of vitamin D on vascular calcification: Clinical implications. Mol Aspects Med 2008;29:423-432
15. Zittermann A, Koerfer R. Vitamin D in the prevention and treatment of coronary heart disease. Curr Opin Clin Nutr Metab Care 2008;11:752-757
16. Wolf M, Shah A, Gutierrez O, et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 2007;72:1004-1013 (Pubitemid 47530570)
17. Zittermann A, Schleithoff SS, Gotting C, et al. Poor outcome in endstage heart failure patients with low circulating calcitriol levels. Eur J Heart Fail 2008;10:321-327
18. Shi H, Dirienzo D, Zemel MB. Effects of dietary calcium on adipocyte lipid metabolism and body weight regulation in energy-restricted aP2-agouti transgenic mice. FASEB J 2001;15:291-293
19. Zemel MB, Shi H, Greer B, Dirienzo D, Zemel PC. Regulation of adiposity by dietary calcium. FASEB J 2000;14:1132-1138
20. Caan B, Neuhouser M, Aragaki A, et al. Calcium plus vitamin D supplementation and the risk of postmenopausal weight gain. Arch Intern Med 2007;167:893-902. (Pubitemid 46762751)
21. Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 2007;30:980-986 (Pubitemid 46556596)
22. Major GC, Alarie F, Doré J, Phouttama S, Tremblay A. Supplementation with calcium 1 vitamin D enhances the beneficial effect of weight loss on plasma lipid and lipoprotein concentrations. Am J Clin Nutr 2007;85:54-59 (Pubitemid 46067615)
23. Vieth R, Bischoff-Ferrari H, Boucher B, et al. The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr 2007;85:649-650 (Pubitemid 46393494)
24. Aloia JF, Patel M, Dimaano R, et al. Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration. Am J Clin Nutr 2008;87:1952-1958 (Pubitemid 351872664)
25. Volkert D, Kreuel K, Heseker H, Stehle P. Energy and nutrient intake of young-old, old-old, and very-old elderly in Germany. Eur J Clin Nutr 2004;58:1190-1200 (Pubitemid 39172394)
26. Ainsworth BE, Haskell WL, Leon AS, et al. Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc 1993;25:71-80.
27. Ainsworth BE, Haskell WL, Whitt MC, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000;32(Suppl):S498-504.
28. Frey I, Berg A, Grathwohl D, Keul J. [Freiburg Questionnaire of physical activity - development, evaluation and application.] Soz Praventivmed 1999;44:55-64(in German).
29. Martins D, Wolf M, Pan D, et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2007;167:1159-1165 (Pubitemid 46919818)
30. Cho HJ, Kang HC, Choi SA, Ju YC, Lee HS, Park HJ. The possible role of Ca21 on the activation of microsomal triglyceride transfer protein in rat hepatocytes. Biol Pharm Bull 2005;28:1418-1423
31. Barger-Lux MJ, Heaney RP, Lanspa SJ, Healy JC, DeLuca HF. An investigation of sources of variation in calcium absorption efficiency. J Clin Endocrinol Metab 1995;80:406-411
32. Lacour B, Basile C, Drüeke T, Funck-Brentano JL. Parathyroid function and lipid metabolism in the rat. Miner Electrolyte Metab 1982;7:157-165 (Pubitemid 12082837)
33. Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. Hypovitaminosis D in medical inpatients. N Engl J Med 1998;338:777-783
34. Andersson P, Rydberg E, Willenheimer R. Primary hyperparathyroidism and heart disease - a review. Eur Heart J 2004;25:1776-1787 (Pubitemid 39330228)
35. Garcia de la Torre N, Wass JA, Turner HE. Parathyroid adenomas and cardiovascular risk. Endocr Relat Cancer 2003;10:309-322
36. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004;15:2208-2218 (Pubitemid 39031360)
37. Sambrook PN, Chen JS, March LM, et al. Serum parathyroid hormone is associated with increased mortality independent of 25-hydroxy vitamin d status, bone mass, and renal function in the frail and very old: a cohort study. J Clin Endocrinol Metab 2004;89:5477-5481
38. Zittermann A, Sabatschus O, Jantzen S, et al. Exercise-trained young men have higher calcium absorption rates and plasma calcitriol levels in comparison to age-matched sedentary controls. Calcif Tissue Int 2000;67:215-219 (Pubitemid 30643858)
39. Scheld K, Zittermann A, Heer M, et al. Nitrogen metabolism and bone metabolism markers in healthy adults during 16 weeks of bed rest. Clin Chem 2001;47:1688-1695 (Pubitemid 32781584)
40. Dunlay SM, Weston SA, Redfield MM, Killian JM, Roger VL. Tumor necrosis factor-alpha and mortality in heart failure: a community study. Circulation 2008;118:625-631
41. Morange PE, Tregouet DA, Godefroy T, et al. Polymorphisms of the tumor necrosis factor-alpha (TNF) and the TNF-alpha converting enzyme (TACE/ADAM17) genes in relation to cardiovascular mortality: the AtheroGene study. J Mol Med 2008;86:1153-1161
42. Van Lente F. Markers of inflammation as predictors in cardiovascular disease. Clin Chim Acta 2000;293:31-52. (Pubitemid 30103554)
43. Schleithoff SS, Zittermann A, Tenderich G, et al. Supplementation improves cytokine profile in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 2006;83:754-759 (Pubitemid 44713136)
44. Haug CJ, Aukrist P, Haug E, Markrid L, Müller F, Froland SS. Severe deficiency of 1,25-dihydroxyvitamin D3 in human immunodeficiency virus infection: association with immunological hyperactivity and only minor changes in calcium homeostasis. J Clin Endocrinol Metab 1998;83:3832-3838 (Pubitemid 28513558)
45. Denke MA, Fox MM, Schulte MC. Short-term dietary calcium fortification increases fecal saturated fat content and reduces serum lipids in men. J Nutr 1993;123:1047-1053
46. Reid IR. Effects of calcium supplementation on circulating lipids: potential pharmacoeconomic implications. Drugs Aging 2004;21:7-17.
47. Vaskonen T, Mervaala E, Sumuvuori V, Seppänen-Laakso T, Karppanen H. Effects of calcium and plant sterols on serum lipids in obese Zucker rats on a low-fat diet. Br J Nutr 2002;87:239-245 (Pubitemid 34295976)
48. Van der Meer R, Welberg JW, Kuipers F, et al. Effects of supplemental dietary calcium on the intestinal association of calcium, phosphate, and bile acids. Gastroenterology 1990;99:1653-1659
49. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. Washington, DC: National Academy Press, 1997:250-287
50. Giovannucci E. Dietary influences of 1,25(OH)2 vitamin D in relation to prostate cancer: a hypothesis. Cancer Causes Control 1998;9:567-582
51. Grimes DS. Are statins analogues of vitamin D? Lancet 2006;368:83-86
52. Pittas A, Dawson-Hughes B, Li T, et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 2006;29:650-656 (Pubitemid 44115368)
53. Krause R, Bühring M, Hopfenmüller W, Holick MF, Sharma AM. Ultraviolet B and blood pressure. Lancet 1998;352:709-710